The neuroprotective effect of overexpression of calbindin-D28k in an animal model of Parkinson's disease

Molecular Neurobiology

Volumn 47, Issue 1, 2013, Pages 117-122

  Yuan, Hong Hua ^a   Chen, Ren Jin ^a   Zhu, Yu Hua ^a   Peng, Chang Ling ^a   Zhu, Xiao Rong ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Dopamine; Parkinson's disease; Transgenic mice

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CALBINDIN; CASPASE 3; DOPAMINE; PROTEIN BCL 2; TYROSINE 3 MONOOXYGENASE;

CORPUS STRIATUM; DISEASE MODEL; DOPAMINERGIC NERVE CELL; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; LIQUID CHROMATOGRAPHY; MESENCEPHALON; MOUSE; NERVE FIBER GROWTH; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PROTEIN EXPRESSION; REVIEW; SUBSTANTIA NIGRA; WESTERN BLOTTING; WILD TYPE;

EID: 84872495686     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-012-8332-3     Document Type: Review

References (17)

1. Polymeropulos MH, Higgins JJ, Golbe LI, Johnson WG, Ide SE, Di IG, Sanges G, Stenroos ES, Pho LT, Schaffer AA, Lazzarini AM, Nussbaum RL, Duvoisin RC (1996) Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science 274:1197-1199
2. Baimbridge KG, Celio MR, Rogers JH (1992) Calcium-binding proteins in the nervous system. Trends Neurosci 15:303-308
3. Slemmer JE, de Zeeuw CI, Weber JT (2005) Don't get too excited: mechanism of glutamate mediated Purkinje cell death. Prog Brain Res 148:367-390
4. Yamada T, McGeer PL, Baimbridge KG, McGeer EG (1990) Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-28 k. Brain Res 526:303-307
5. Reisner PD, Christakos S, Vanaman TC (1992) In vitro enzyme activation with calbindin-D28k, the vitamin D-dependent 28 kDa calcium binding protein. FEBS Let 297:127-131
6. Lavoie B, Parent A (1991) Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys. Neuroreport 2:601-604
7. Iacopino AM, Christakos S, German D, Sonsalla PK, Altar CA (1992) Calbindin-D28k-containing neurons in animal models of neurodegeneration: possible protection from excitotoxicity. Mol Brain Res 13:251-261
8. 28k levels in mouse midbrain dopaminergic neurons. Mol Brain Res 36:329-336
9. Airaksinen MS, Thoenen H, Meyer M (1997) Vulnerability of midbrain dopaminergic neurons in calbindin-D28k-deficient mice: lack of evidence for a neuroprotective role of endogenous calbindin in MPTP-treated and weaver mice. Eur J Neurosci 9:120-127
10. Choi WS, Lee E, Lim J, Oh YJ (2008) Calbindin-D28K prevents drug-induced dopaminergic neuronal death by inhibiting caspase and calpain activity. Biochem Biophys Res Commun 371:127-131
11. Janicke RU, Sprengart ML, Wati MR, Porter AG (1998) Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 273:9357-9360
12. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X (1997) Prevention of apoptosis by Bcl-2: release of cytochrome from mitochondria blocked. Science 275:1129-1132
13. Lowry DH, Rosebrough HJ, Rarr AL (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193:265-275
14. Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leventhal L, McBride J, Chen EY, Palfi S, Roitberg BZ, Brown WD, Holden JE, Pyzalski R, Taylor MD, Carvey P, Ling Z, Trono D, Hantraye P, Déglon N, Aebischer P (2000) Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models Parkinson's disease. Science 290:767-773
15. Howard K (2003) First Parkinson gene therapy trial launches. Nat Biotech 21:1117-1118
16. Iacopino AM, Quintero ME, Miller EK (1994) Calbindin-D28k: a potential neuroprotective protein. Neurodegeneration 3:1-20
17. Bellido T, Huening M, Raval-Pandya M, Manolagas SC, Christakos S (2000) Calbindin-D28k is expressed in osteoblastic cells and suppresses their apoptosis by inhibiting caspase-3 activity. J Biol Chem 275:26328-26332